Stocks
Axsome Therapeutics (AXSM) EV/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -29.2 | -11.2 | -18.0 | -17.4 | -15.2 | -9.80 | ||
| Changes by years, y/y, % | -41% | -62% | +60% | -3% | -13% | +48.4% | |||
Axsome Therapeutics. EV/EBITDA
Axsome Therapeutics. EV/EBITDA, changes, %
Axsome Therapeutics (AXSM) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -17.4 | -16.3 | -13.0 | -12.3 | -13.8 | -9.80 | |
| Changes by years, y/y, % | +50% | -14% | -31% | -33% | -20% | |||
| Changes by quarters, q/q, % | -6% | -6% | -20% | -5% | +12% | |||
